130 related articles for article (PubMed ID: 33486038)
1. Exploring the therapeutic potential of the bioinspired reconstituted high density lipoprotein nanostructures.
Gupta A; Sharma R; Kuche K; Jain S
Int J Pharm; 2021 Mar; 596():120272. PubMed ID: 33486038
[TBL] [Abstract][Full Text] [Related]
2. Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research.
Kornmueller K; Vidakovic I; Prassl R
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382521
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Anti-Atherosclerotic Efficacy of pH-Responsively Releasable Ganglioside GM3 Delivered by Reconstituted High-Density Lipoprotein.
Rong T; Wei B; Ao M; Zhao H; Li Y; Zhang Y; Qin Y; Zhou J; Zhou F; Chen Y
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948420
[TBL] [Abstract][Full Text] [Related]
4. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
5. Reconstituted high density lipoprotein-based nanoparticles: an overview of applications in regenerative medicine, preparation, evaluation and future trends.
Wang X; Zhou J; Wang W
Curr Pharm Des; 2015; 21(12):1529-44. PubMed ID: 25594411
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional Dextran Sulfate-Coated Reconstituted High Density Lipoproteins Target Macrophages and Promote Beneficial Antiatherosclerotic Mechanisms.
Zhao Y; Jiang C; He J; Guo Q; Lu J; Yang Y; Zhang W; Liu J
Bioconjug Chem; 2017 Feb; 28(2):438-448. PubMed ID: 28004910
[TBL] [Abstract][Full Text] [Related]
7. Reconstituted HDL as a therapeutic delivery device.
Fox CA; Moschetti A; Ryan RO
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Nov; 1866(11):159025. PubMed ID: 34375767
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of reconstituted high-density lipoprotein (rHDL) as a drug delivery platform - a detailed survey of rHDL particles ranging from biophysical properties to clinical implications.
Simonsen JB
Nanomedicine; 2016 Oct; 12(7):2161-2179. PubMed ID: 27237620
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoprotein-biomimetic nanocarriers for glioblastoma-targeting delivery: the effect of shape.
Huang JL; Jiang G; Song QX; Gu X; Song HH; Wang XL; Jiang D; Kang T; Feng XY; Jiang XG; Chen HZ; Gao XL
Pharmazie; 2016 Dec; 71(12):709-714. PubMed ID: 29441999
[TBL] [Abstract][Full Text] [Related]
10. Engineered rHDL Nanoparticles as a Suitable Platform for Theranostic Applications.
Aranda-Lara L; Isaac-Olivé K; Ocampo-García B; Ferro-Flores G; González-Romero C; Mercado-López A; García-Marín R; Santos-Cuevas C; Estrada JA; Morales-Avila E
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296638
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of garcinia glycosides by reconstituted high-density lipoprotein nano-complexes.
Liu C; Zhou Z; Chen Y; Liu J; Wang Y; Liu H
J Microencapsul; 2018 Mar; 35(2):115-120. PubMed ID: 29195484
[TBL] [Abstract][Full Text] [Related]
12. Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy.
Wang Y; Wang C; Ding Y; Li J; Li M; Liang X; Zhou J; Wang W
Colloids Surf B Biointerfaces; 2016 Dec; 148():533-540. PubMed ID: 27690242
[TBL] [Abstract][Full Text] [Related]
13. Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy.
Mei Y; Tang L; Xiao Q; Zhang Z; Zhang Z; Zang J; Zhou J; Wang Y; Wang W; Ren M
J Mater Chem B; 2021 Jan; 9(3):612-633. PubMed ID: 33306079
[TBL] [Abstract][Full Text] [Related]
14. Everolimus-Loaded Reconstituted High-Density Lipoprotein Prepared by a Novel Dual Centrifugation Approach for Anti-Atherosclerotic Therapy.
Deuringer B; Härdtner C; Krebs K; Thomann R; Holzer M; Hilgendorf I; Süss R
Int J Nanomedicine; 2022; 17():5081-5097. PubMed ID: 36340183
[TBL] [Abstract][Full Text] [Related]
15. Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model.
Zhang WL; Xiao Y; Liu JP; Wu ZM; Gu X; Xu YM; Lu H
Int J Pharm; 2011 Oct; 419(1-2):314-21. PubMed ID: 21835236
[TBL] [Abstract][Full Text] [Related]
16. Reconstituted high-density lipoproteins: novel biomimetic nanocarriers for drug delivery.
Ma X; Song Q; Gao X
Acta Pharm Sin B; 2018 Jan; 8(1):51-63. PubMed ID: 29872622
[TBL] [Abstract][Full Text] [Related]
17. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
[TBL] [Abstract][Full Text] [Related]
18. Mimic Lipoproteins Responsive to Intratumoral pH and Allosteric Enzyme for Efficient Tumor Therapy.
Li J; Wang H; Xu J; Wu S; Han M; Li J; Wang Q; Ge Z
ACS Appl Mater Interfaces; 2022 Jan; 14(1):404-416. PubMed ID: 34962752
[TBL] [Abstract][Full Text] [Related]
19. Endocytic recycling as cellular trafficking fate of simvastatin-loaded discoidal reconstituted high-density lipoprotein to coordinate cholesterol efflux and drug influx.
Qi Z; Jiang C; Gao H; Wang Y; Zhang Q; Zhang W; Liu J
Nanomedicine; 2021 Feb; 32():102323. PubMed ID: 33186693
[TBL] [Abstract][Full Text] [Related]
20. Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles.
Sabnis N; Nair M; Israel M; McConathy WJ; Lacko AG
Int J Nanomedicine; 2012; 7():975-83. PubMed ID: 22393294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
